Cheongwon, South Korea
Cheongwon, South Korea

Time filter

Source Type

Cho J.-H.,Hurum Central Research Institute Co. | Park I.-J.,Hurum Central Research Institute Co. | Baik S.-O.,Hurum Central Research Institute Co. | Choi S.-Y.,Chungbuk National University | Choi G.-H.,Hurum Central Research Institute Co.
Korean Journal of Food Science and Technology | Year: 2014

In this study, the products of Acanthopanax senticosus fermentation were derived from the mycelia of 2 mushrooms, Ganoderma lucidum and Phellinus linteus, to determine their safety in Sprague-Dawley rats. Rats were orally administered the water extracts of A. senticosus fermentation products with G. lucidum (FM-5111) or P. linteus (FM-5131) at dose levels of 0.5, 1.0, or 2.0 g/kg for the single-dose toxicity test and 0.25, 0.5, or 1.0 g/kg for the repeated-dose toxicity test. There were no significant differences in body weight gain, feed intake, or water consumption between control and FM-5111- or FM-5131-treated rats. Hematological and blood biochemistry analysis revealed that none of the investigated parameters were affected by the A. senticosus fermentation products, and no remarkable lesions were observed upon histopathological analysis. We conclude that the A. senticosus fermentation products obtained from mushroom mycelia are safe for long-term administration and could be considered as multi-functional nutrients for the improvement of liver function and immunity. copyright © 2014 The Korean Society of Food Science and Technology.


Cho J.-H.,Hurum Central Research Institute Co. | Park I.-J.,Hurum Central Research Institute Co. | Choi S.-Y.,Chungbuk National University | Baik S.-O.,Hurum Central Research Institute Co. | Kim C.-S.,Hurum Central Research Institute Co.
Journal of the Korean Society of Food Science and Nutrition | Year: 2014

We demonstrated that Acanthopanax senticosus fermentation products (FM-5111 and FM-5131) administered to rats functionally protect against DL-ethionine-induced and ethanol-induced fatty liver models. In DL-ethionine- induced fatty liver models, the serum concentrations of aspartate aminotransferase (AST), as well as liver concentrations of triglyceride and total lipid against the control decreased in FM-5111 and FM-5131 treated rats. In ethanol-induced fatty liver models, FM-5111 and FM-5131 treated rats showed a decrease in the liver concentrations of triglyceride and total lipid in ethanol-induced fatty liver models. There were no significant differences in the serum concentrations of AST and alanine aminotransferase in FM-5111 and FM-5131 treated rats. Additionally, FM-5111-, or FM-5131- treated rats showed no significant differences in the body weight gain between the control. These results indicate that Acanthopanax senticosus fermentation products might have protective effects against DL-ethionine-induced and ethanol-induced fatty liver models.

Loading Hurum Central Research Institute Co. collaborators
Loading Hurum Central Research Institute Co. collaborators